Takeda Pharmaceutical Co Ltd  

(Public, TYO:4502)   Watch this stock  
Find more results for 4502
6,289.00
+41.00 (0.66%)
Delayed:   10:26AM GMT+9
TYO data delayed by 20 mins - Disclaimer
Currency in JPY
Range 6,261.00 - 6,307.00
52 week 4,337.50 - 6,657.00
Open 6,280.00
Vol. 634,600.00
Mkt cap 4.97T
P/E 65.74
Div/yield 90.00/2.86
EPS 95.66
Shares 785.85M
Beta     -
Inst. own     -
May 15, 2015
Full Year 2015 Takeda Pharmaceutical Co Ltd Earnings Presentation (Japanese) - 5:00PM GMT+9 - Add to calendar
May 15, 2015
Full Year 2015 Takeda Pharmaceutical Co Ltd Earnings Release - 3:00PM GMT+9 - Add to calendar
Mar 9, 2015
Takeda Pharmaceutical Co Ltd to Discuss Entyvio and GI Franchise
Feb 5, 2015
Q3 2015 Takeda Pharmaceutical Co Ltd Earnings Call (Japanese)
Feb 5, 2015
Q3 2015 Takeda Pharmaceutical Co Ltd Earnings Call Webcast
Feb 5, 2015
Q3 2015 Takeda Pharmaceutical Co Ltd Earnings Release
  

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 3.93% 6.48%
Operating margin 16.85% 8.48%
EBITD margin - 21.88%
Return on average assets 1.67% 2.54%
Return on average equity 2.96% 4.50%
Employees 31,225 -
CDP Score - 96 B

Address

4-1-1, Dosho-machi, Chuo-ku
OSAKA-SHI, OSK 540-8645
Japan
+81-6-62042111 (Phone)
+81-6-62042880 (Fax)

Website links

External links

Description

Takeda Pharmaceutical Company Limited is a Japan-based company engaged in the pharmaceutical business. The Ethical Pharmaceutical segment is engaged in the manufacture and sale of pharmaceutical products, such as therapeutic substances for diabetes, circulatory drugs, anticancer drugs, drugs for central neurological diseases, digestive system drugs, hormonal agents, osteoporosis drugs, antibiotic agents, allergy medications, vitamin drops and vaccines, among others. The Healthcare segment manufactures and sells general drugs and medicines, as well as quasi drugs. The Others segment is involved in the manufacture and sale of reagents, clinical diagnostics and chemical products. As of March 31, 2014, the Company had 146 subsidiaries and 17 associated companies.

Officers and directors

Yasuchika Hasegawa Chairman of the Board, Representative Director
Age: 68
Christophe Weber President, Chief Executive Officer, Representative Director
Age: 48
Frank Morich Chief Commercial Officer, President of Subsidiary, Director
Age: 59
Ramona Sequeira President - United States (U.S.) Business Unit
Tadataka Yamada M.D. Chief Medical and Scientific Officer, Director
Age: 69
Yasuhiko Yamanaka Managing Director
Age: 57
Masato Iwasaki Chief Director of Pharmaceutical Sales, Director
Age: 54
Shinji Honda Director of Business Planning, Director
Age: 55
Yorihiko Kojima Independent Director
Age: 72
Fumio Sudo Independent Director
Age: 74